STRS Ohio’s Passage Bio PASG Stock Holding History

STRS Ohio’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-175	Closed	-$89K	–	2253
2020 Q4	$89K	Hold	175	–	–	﹤0.01%	1911
2020 Q3	$45K	Hold	175	–	–	﹤0.01%	1990
2020 Q2	$95K	Buy	+175	New	+$78.7K	﹤0.01%	1800

Other funds holding PASG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's PASG Position: Q1 2021 in Review

STRS Ohio sold out of Passage Bio (PASG) in Q1 2021, closing a stake of 175 shares — an estimated $89K sold.

STRS Ohio first reported a position in PASG in Q2 2020 and held it in 3 quarters. The position peaked at $95K in Q2 2020. 89 funds tracked by Wall St. Rank hold PASG as of Q1 2021.

STRS Ohio reported no remaining Passage Bio position as of Q1 2021 after selling out during the quarter.
STRS Ohio sold 175 Passage Bio shares in Q1 2021, an estimated $89K.
STRS Ohio first reported a position in Passage Bio in Q2 2020 and held it in 3 quarters.
STRS Ohio's Passage Bio position peaked at $95K in Q2 2020.
89 funds tracked by Wall St. Rank held Passage Bio as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.